2
Most read
8
Most read
12
Most read
Calculating
Person-Time
Dr. Mohammed Jawad
What is
person-time?
 Person-time is an estimate of the actual time-at-risk – in years,
months, or days – that all participants contributed to a study.
 In certain studies people are followed for different lengths of time,
as some will remain free of a health outcome or disease longer than
others.
 A subject is eligible to contribute person-time to the study only so
long as that person does not yet have the health outcome under
study and, therefore, is still at risk of developing the health outcome
of interest.
 By knowing the number of new cases of the health outcome and the
person-time-at-risk contributed to the study, an investigator can
calculate the rate of the health outcome or disease, or how quickly
people are acquiring the health outcome or disease.
Calculatingrates
 The rate is the
number of new
(incident) cases
during study follow-
up divided by the
person-time-at risk
throughout the
observation period.
Calculating
rates
 The denominator for a rate (person time) is a
more exact expression of the population at risk
during the period of time when the change from
non-disease to disease is being measured.
 The denominator for the rate changes as persons
originally at risk develop the health outcome
during the observation period and are removed
from the denominator.
Calculating person-time
for rates
 Now suppose an investigator is
conducting a study of the rate of
second myocardial infarction
(MI). He follows 5 subjects
from baseline (first MI) for up
to 10 weeks. The results are
graphically displayed as
follows:
Calculating
person-time
for rates
 The graph shows how many days each subject
remained in the study as a non-case (no second
MI) from baseline. From this graph the
investigator can calculate person- time. Person-
time is the sum of total time contributed by all
subjects. The unit for person-time in this study
is person-days (p-d).
Calculating
person-time
for rates
Time contributed by each subject:
A. Subject A: 53 days
B. Subject B: 70 days
C. Subject C: 24 days
D. Subject D: 70 days
E. Subject E: 19 days
Total person-days in the study:
53+70+24+70+19=236 person-days
Calculating
person-time
for rates
 236 person-days (p-d) now becomes the
denominator in the rate measure. The total
number of subjects becoming cases (subjects A,
C, and E) is the numerator in the rate measure.
Therefore the rate of secondary MI is 3/(236 p-
d), which is 0.0127 cases per person-day. By
multiplying the numerator and denominator by
1000, the rate becomes 12.7 cases per 1000
person-days.
Calculating
person-time
for rates
 The denominator, person-days, can be converted
into other time units (such as hours or years)
appropriate to the disease or health outcome
being studied.
 Secondary MI may be expressed in cases per
person-year (p-y) by: (0.0127 cases/p-d) x (365
p-d/1 p-y) = 4.6 cases/ p-y
Estimating
when a person
becomes a
case
Now suppose an investigator is studying the rate
of prostate cancer in men with a family history of
prostate cancer. Subjects are examined once a
year for up to five years. In order to calculate
person-time when an investigator is only
examining patients at specified intervals (once a
year) the investigator must determine when a
newly diagnosed case acquired the disease within
the last year.
Estimating
when a person
becomes a
case
In order to determine the amount of person-time
adequately, an investigator may decide that the
onset of prostate cancer occurred at the midpoint
of the time interval between being disease free
and becoming a case. This is because the
investigator does not know precisely when
subject A developed prostate cancer (just that it
was sometime between exams two and three).
Estimating
when a person
becomes a
case
The following graph displays the
amount of time until onset of
prostate cancer for each subject.
Time contributed by each subject:
A. Subject A: 2.5 years
B. Subject B: 5 years
C. Subject C: 1.5 years
D. Subject D: 5 years
E. Subject E: 0.5 years
Total person-years in the study:
(2.5+5+1.5+5+0.5)=14.5 person-
years
14.5 p-y is the denominator in the
rate of prostate cancer.
Terminology
 Rate: the number of new cases of disease during
a period of time divided by the person-time-at-
risk
 Person-time: estimate of the actual time-at-risk
in years, months, or days that all persons
contributed to a study
Practice
Questions
Researchers are studying the rate of developing
asthma. The researchers enroll 100 participants
who have been determined to not have asthma.
The researchers plan to follow these participants
over one year to see who develops asthma,
beginning on January 1st. Participants visit a
doctor monthly, at the end of the month, to
determine if they have asthma. After one year, 5
of the participants have developed asthma. Two
participants had asthma diagnosed at the end of
March. Two participants had asthma diagnosed at
the end of August. One participant had asthma
diagnosed at the end of November.
Practice
Questions
Q1) How many person-months did the study
participants contribute to the study, assuming that
patients became cases of asthma on the last day of
the month when they were diagnosed?
Practice
Questions
Q2) What is the rate of asthma cases in this
study?
Practice
Questions
Q3) In this study, when were participants
removed from the denominator of the rate?
Reference
Alexander LK, Lopes B, Ricchetti-Masterson K,
Yeatts KB. Calculating Person Time.
Epidemiologic Research and Information Center
(ERIC) Notebook. Second Edition. 2015.

More Related Content

PPTX
Cardiac Amyloidosis
PDF
Anesthetics - Pharmacology
PPT
Epidemiology for nursing student
PPTX
Amoebiasis
PPTX
Quality in hospital
PPT
2.epidemilogic measures
PPTX
Non communicable disease
PPT
Epidemiology Study Design
Cardiac Amyloidosis
Anesthetics - Pharmacology
Epidemiology for nursing student
Amoebiasis
Quality in hospital
2.epidemilogic measures
Non communicable disease
Epidemiology Study Design

What's hot (20)

PPTX
Incidence or incidence rate (Epidemiology short lecture)
PPSX
Relative and Atribute Risk
PPTX
Prevalence and incidence
PPTX
Nested case control,
PPT
DESCRIPTIVE EPIDEMIOLOGY
PPTX
Case control study
PPTX
Measures of disease frequency
PDF
Rate, ratio, proportion
PPTX
Basic concepts and principles of epidemiology
PDF
Cross sectional study
PPT
Incidence And Prevalence
PPTX
Cross sectional study by Dr Abhishek Kumar
PPTX
DALYs and QALYs by samrat gurung
PPTX
Nested case control study
PPTX
Epidemiology lecture 2 measuring disease frequency
PPT
Investigation of epidemic presentation
PPT
Attributable risk and population attributable risk
PPTX
Chapter 2.2 screening test
PPTX
Cross sectional study
PPTX
Epidemiology Exercises
Incidence or incidence rate (Epidemiology short lecture)
Relative and Atribute Risk
Prevalence and incidence
Nested case control,
DESCRIPTIVE EPIDEMIOLOGY
Case control study
Measures of disease frequency
Rate, ratio, proportion
Basic concepts and principles of epidemiology
Cross sectional study
Incidence And Prevalence
Cross sectional study by Dr Abhishek Kumar
DALYs and QALYs by samrat gurung
Nested case control study
Epidemiology lecture 2 measuring disease frequency
Investigation of epidemic presentation
Attributable risk and population attributable risk
Chapter 2.2 screening test
Cross sectional study
Epidemiology Exercises
Ad

Similar to Calculating person time (20)

PPT
4- Measures of Disease Occurrencefffffffffffff.ppt
PPTX
Final methods epidemiology
PDF
mudule 3 Measure of health and Health Related Events.pdf
PPTX
Survival analysis
PPTX
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
PPTX
APPROACH TO BASIC EPIDEMIOLOGICAL DESIGNS.pptx
PPTX
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
PDF
83341ch12jacobsen-150812175733-lva1-app6891.pdf
PPTX
83341 ch12 jacobsen
DOCX
Epidemiology Depuk sir_ 1,2,3 chapter,OK
PPTX
Cohort, case control & survival studies-2014
PDF
B04621019
PPTX
Mesurement of morbidity (prevalence) presentation
PPTX
Statistics and biostatistics
PPTX
bio 1 & 2.pptx
DOCX
Course Project Phase TwoPavel GarbuzApril 12th, 2017.docx
PDF
A gentle introduction to survival analysis
PPTX
Research methodology
DOCX
Dr. Obumneke Amadi Transcripts June_ P2_2017
PDF
Study-Designs-in-Epidemiology-2.pdf
4- Measures of Disease Occurrencefffffffffffff.ppt
Final methods epidemiology
mudule 3 Measure of health and Health Related Events.pdf
Survival analysis
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
APPROACH TO BASIC EPIDEMIOLOGICAL DESIGNS.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
83341ch12jacobsen-150812175733-lva1-app6891.pdf
83341 ch12 jacobsen
Epidemiology Depuk sir_ 1,2,3 chapter,OK
Cohort, case control & survival studies-2014
B04621019
Mesurement of morbidity (prevalence) presentation
Statistics and biostatistics
bio 1 & 2.pptx
Course Project Phase TwoPavel GarbuzApril 12th, 2017.docx
A gentle introduction to survival analysis
Research methodology
Dr. Obumneke Amadi Transcripts June_ P2_2017
Study-Designs-in-Epidemiology-2.pdf
Ad

More from Kadium (8)

PPTX
Common statistical tests and applications in epidemiological literature
PPTX
Cohort Studies by Dr. Mohammed Jawad 2020
PPTX
Case control studies
PPTX
Common measures and statistics in epidemiological literature
PPTX
Common statistical tests and applications in epidemiological literature
PPTX
Common statistical tests and applications in epidemiological literature
PPTX
Incident vs.Prevalent cases and Measures of Occurrence
PPTX
Healthcare epidemiology and the Population Perspectives
Common statistical tests and applications in epidemiological literature
Cohort Studies by Dr. Mohammed Jawad 2020
Case control studies
Common measures and statistics in epidemiological literature
Common statistical tests and applications in epidemiological literature
Common statistical tests and applications in epidemiological literature
Incident vs.Prevalent cases and Measures of Occurrence
Healthcare epidemiology and the Population Perspectives

Recently uploaded (20)

PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
Effects of lipid metabolism 22 asfelagi.pptx
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PDF
Calcified coronary lesions management tips and tricks
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
Neonate anatomy and physiology presentation
PPT
Rheumatology Member of Royal College of Physicians.ppt
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
thio and propofol mechanism and uses.pptx
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
Lecture 8- Cornea and Sclera .pdf 5tg year
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Wheat allergies and Disease in gastroenterology
Effects of lipid metabolism 22 asfelagi.pptx
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Vaccines and immunization including cold chain , Open vial policy.pptx
OSCE Series Set 1 ( Questions & Answers ).pdf
OSCE Series ( Questions & Answers ) - Set 6.pdf
Calcified coronary lesions management tips and tricks
Approach to chest pain, SOB, palpitation and prolonged fever
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Neonate anatomy and physiology presentation
Rheumatology Member of Royal College of Physicians.ppt
PEADIATRICS NOTES.docx lecture notes for medical students
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
thio and propofol mechanism and uses.pptx

Calculating person time

  • 2. What is person-time?  Person-time is an estimate of the actual time-at-risk – in years, months, or days – that all participants contributed to a study.  In certain studies people are followed for different lengths of time, as some will remain free of a health outcome or disease longer than others.  A subject is eligible to contribute person-time to the study only so long as that person does not yet have the health outcome under study and, therefore, is still at risk of developing the health outcome of interest.  By knowing the number of new cases of the health outcome and the person-time-at-risk contributed to the study, an investigator can calculate the rate of the health outcome or disease, or how quickly people are acquiring the health outcome or disease.
  • 3. Calculatingrates  The rate is the number of new (incident) cases during study follow- up divided by the person-time-at risk throughout the observation period.
  • 4. Calculating rates  The denominator for a rate (person time) is a more exact expression of the population at risk during the period of time when the change from non-disease to disease is being measured.  The denominator for the rate changes as persons originally at risk develop the health outcome during the observation period and are removed from the denominator.
  • 5. Calculating person-time for rates  Now suppose an investigator is conducting a study of the rate of second myocardial infarction (MI). He follows 5 subjects from baseline (first MI) for up to 10 weeks. The results are graphically displayed as follows:
  • 6. Calculating person-time for rates  The graph shows how many days each subject remained in the study as a non-case (no second MI) from baseline. From this graph the investigator can calculate person- time. Person- time is the sum of total time contributed by all subjects. The unit for person-time in this study is person-days (p-d).
  • 7. Calculating person-time for rates Time contributed by each subject: A. Subject A: 53 days B. Subject B: 70 days C. Subject C: 24 days D. Subject D: 70 days E. Subject E: 19 days Total person-days in the study: 53+70+24+70+19=236 person-days
  • 8. Calculating person-time for rates  236 person-days (p-d) now becomes the denominator in the rate measure. The total number of subjects becoming cases (subjects A, C, and E) is the numerator in the rate measure. Therefore the rate of secondary MI is 3/(236 p- d), which is 0.0127 cases per person-day. By multiplying the numerator and denominator by 1000, the rate becomes 12.7 cases per 1000 person-days.
  • 9. Calculating person-time for rates  The denominator, person-days, can be converted into other time units (such as hours or years) appropriate to the disease or health outcome being studied.  Secondary MI may be expressed in cases per person-year (p-y) by: (0.0127 cases/p-d) x (365 p-d/1 p-y) = 4.6 cases/ p-y
  • 10. Estimating when a person becomes a case Now suppose an investigator is studying the rate of prostate cancer in men with a family history of prostate cancer. Subjects are examined once a year for up to five years. In order to calculate person-time when an investigator is only examining patients at specified intervals (once a year) the investigator must determine when a newly diagnosed case acquired the disease within the last year.
  • 11. Estimating when a person becomes a case In order to determine the amount of person-time adequately, an investigator may decide that the onset of prostate cancer occurred at the midpoint of the time interval between being disease free and becoming a case. This is because the investigator does not know precisely when subject A developed prostate cancer (just that it was sometime between exams two and three).
  • 12. Estimating when a person becomes a case The following graph displays the amount of time until onset of prostate cancer for each subject. Time contributed by each subject: A. Subject A: 2.5 years B. Subject B: 5 years C. Subject C: 1.5 years D. Subject D: 5 years E. Subject E: 0.5 years Total person-years in the study: (2.5+5+1.5+5+0.5)=14.5 person- years 14.5 p-y is the denominator in the rate of prostate cancer.
  • 13. Terminology  Rate: the number of new cases of disease during a period of time divided by the person-time-at- risk  Person-time: estimate of the actual time-at-risk in years, months, or days that all persons contributed to a study
  • 14. Practice Questions Researchers are studying the rate of developing asthma. The researchers enroll 100 participants who have been determined to not have asthma. The researchers plan to follow these participants over one year to see who develops asthma, beginning on January 1st. Participants visit a doctor monthly, at the end of the month, to determine if they have asthma. After one year, 5 of the participants have developed asthma. Two participants had asthma diagnosed at the end of March. Two participants had asthma diagnosed at the end of August. One participant had asthma diagnosed at the end of November.
  • 15. Practice Questions Q1) How many person-months did the study participants contribute to the study, assuming that patients became cases of asthma on the last day of the month when they were diagnosed?
  • 16. Practice Questions Q2) What is the rate of asthma cases in this study?
  • 17. Practice Questions Q3) In this study, when were participants removed from the denominator of the rate?
  • 18. Reference Alexander LK, Lopes B, Ricchetti-Masterson K, Yeatts KB. Calculating Person Time. Epidemiologic Research and Information Center (ERIC) Notebook. Second Edition. 2015.